Zobrazeno 1 - 10
of 167 056
pro vyhledávání: '"Drug development"'
Autor:
Zaragoza Domingo S; Neuropsychological Research Organization s.l. (Neuropsynchro), Barcelona, Spain. Electronic address: szaragoza@psyncro.net., Alonso J; Hospital del Mar Research Institute; CIBER de Epidemiología y Salud Pública, Instituto de Salud Carlos III; Universitat Pompeu Fabra, Barcelona, Spain., Ferrer M; Hospital del Mar Research Institute; CIBER de Epidemiología y Salud Pública, Instituto de Salud Carlos III; Universitat Pompeu Fabra, Barcelona, Spain., Acosta MT; National Human Genome Research Institute (NHGRI), NIH, Washington, USA., Alphs L; Denovo Biopharma, Princeton, New Jersey, USA., Annas P; Alexion Pharmaceuticals, Inc., Copenhagen, Denmark., Balabanov P; European Medicines Agency (EMA), Amsterdam, The Netherlands., Berger AK; H. Lundbeck A/S, Copenhagen, Denmark., Bishop KI; Global Pharma Consultancy, LLC, PA, USA., Butlen-Ducuing F; European Medicines Agency, EMA, Amsterdam, The Netherlands., Dorffner G; The Siesta Group, Vienna, Austria., Edgar C; Cogstate, Ltd., London, UK., de Gracia Blanco M; Universitat de Girona, Girona, Spain., Harel B; Takeda Pharmaceuticals USA Inc, Cambridge, MA, USA., Harrison J; Scottish Brain Sciences, Scotland, UK., Horan WP; Karuna Therapeutics, Boston, MA, USA., Jaeger J; Cognitionmetrics, Stamford, CT, USA., Kottner J; Charité-Universitätsmedizin, Berlin, Germany., Pinkham A; University of Texas Southwestern Medical Center, Dallas, TX, USA., Tinoco D; Worldwide Clinical Trials, Barcelona, Spain., Vance M; Santium, Toronto, Canada., Yavorsky C; Valis Bioscience, Berkeley, CA, USA.
Publikováno v:
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology [Eur Neuropsychopharmacol] 2024 Jun; Vol. 83, pp. 32-42. Date of Electronic Publication: 2024 Apr 04.
Autor:
Edoardo C; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Division of Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Milan, Italy.; Department of Investigational Cancer Therapeutics, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Giuseppe C; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Division of Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Milan, Italy.
Publikováno v:
Expert opinion on investigational drugs [Expert Opin Investig Drugs] 2024 Aug; Vol. 33 (8), pp. 851-865. Date of Electronic Publication: 2024 Jul 09.
Autor:
Galluppi GR; Sumitomo Pharma America, Marlborough, Massachusetts, USA., Ahamadi M; Sanofi US, Bridgewater, New Jersey, USA., Bhattacharya S; Astellas Pharma US Inc., Cambridge, Massachusetts, USA., Budha N; BeiGene USA Inc., San Mateo, California, USA., Gheyas F; Merck & Co., Inc, Rahway, New Jersey, USA., Li CC; Genentech Inc, South San Francisco, California, USA., Chen Y; Genentech Inc, South San Francisco, California, USA., Dosne AG; The Janssen Pharmaceutical Companies of Johnson & Johnson, Beerse, Belgium., Kristensen NR; Novo Nordisk A/S, Bagsvaerd, Denmark., Magee M; GSK, Phoenixville, Pennsylvania, USA., Samtani MN; Johnson & Johnson Innovative Medicine, Raritan, New Jersey, USA., Sinha V; Novartis Institute of Biomedical Research, Berwyn, Pennsylvania, USA., Taskar K; GSK, Stevenage, UK., Upreti VV; Amgen Inc., South San Fracisco, California, USA., Yang J; Astellas Pharma Inc., Northbrook, Illinois, USA., Cook J; A2-Ai LLC, Ann Arbor, Michigan, USA.
Publikováno v:
Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2024 Aug; Vol. 116 (2), pp. 282-288. Date of Electronic Publication: 2024 Mar 22.
Autor:
Michaeli DT; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Im Neuenheimer Feld 460, 69120, Heidelberg, Germany. danielmichaeli@yahoo.com.; TUM School of Management, Technical University of Munich, Munich, Germany. danielmichaeli@yahoo.com., Michaeli T; Department of Personalized Oncology, University Hospital Mannheim, Heidelberg University, Mannheim, Germany.; DKFZ-Hector Cancer Institute at the University Medical Center Mannheim, Mannheim, Germany.; Division of Personalized Medical Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Albers S; Department of Orthopaedics and Sport Orthopaedics, School of Medicine, Klinikum Rechts Der Isar, Technical University of Munich, Munich, Germany., Boch T; Department of Personalized Oncology, University Hospital Mannheim, Heidelberg University, Mannheim, Germany.; DKFZ-Hector Cancer Institute at the University Medical Center Mannheim, Mannheim, Germany.; Division of Personalized Medical Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Michaeli JC; Department of Obstetrics and Gynaecology, LMU University Hospital, LMU Munich, Germany.
Publikováno v:
The European journal of health economics : HEPAC : health economics in prevention and care [Eur J Health Econ] 2024 Aug; Vol. 25 (6), pp. 979-997. Date of Electronic Publication: 2023 Nov 14.
Autor:
Ma Q; Translational Research Laboratory for Urological Diseases, First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang, PR China; Comprehensive Genitourinary Cancer Center, First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang, PR China. Electronic address: fyymaqi@nbu.edu.cn., Durga P; Department of Pharmaceutical Sciences, Texas Tech University Health Sciences Center School of Pharmacy, Amarillo, TX, USA., Wang FXC; Department of Medicine, Houston Methodist Hospital, Houston, TX, USA., Yao HP; State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Center for Infectious Diseases, First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, PR China. Electronic address: yaohangping@zju.edu.cn., Wang MH; Department of Pharmaceutical Sciences, Texas Tech University Health Sciences Center School of Pharmacy, Amarillo, TX, USA. Electronic address: minghai.wang@ttuhsc.edu.
Publikováno v:
Drug discovery today [Drug Discov Today] 2024 Aug; Vol. 29 (8), pp. 104057. Date of Electronic Publication: 2024 Jun 04.
Autor:
Hangyu W; Key Laboratory of Immune Microenvironment and Inflammatory Disease Research in Universities of Shandong Province, School of Basic Medical Sciences, Shandong Second Medical University, Weifang 261053, P.R. China., Panpan L; Key Laboratory of Immune Microenvironment and Inflammatory Disease Research in Universities of Shandong Province, School of Basic Medical Sciences, Shandong Second Medical University, Weifang 261053, P.R. China., Jie S; School of Medical Laboratory, Shandong Second Medical University, Weifang 261053, P.R. China., Hongyan W; Key Laboratory of Immune Microenvironment and Inflammatory Disease Research in Universities of Shandong Province, School of Basic Medical Sciences, Shandong Second Medical University, Weifang 261053, P.R. China., Linmiao W; Key Laboratory of Immune Microenvironment and Inflammatory Disease Research in Universities of Shandong Province, School of Basic Medical Sciences, Shandong Second Medical University, Weifang 261053, P.R. China., Kangning H; Key Laboratory of Immune Microenvironment and Inflammatory Disease Research in Universities of Shandong Province, School of Basic Medical Sciences, Shandong Second Medical University, Weifang 261053, P.R. China., Yichen S; School of Stomatology, Shandong Second Medical University, Weifang 261053, P.R. China., Shuai W; Department of Rheumatology and Immunology, The Affiliated Hospital of Inner Mongolia Medical University, Inner Mongolia 010050, P.R. China.; Inner Mongolia Key Laboratory for Pathogenesis and Diagnosis of Rheumatic and Autoimmune Diseases, Inner Mongolia 010110, P.R. China., Cheng W; Department of Rheumatology and Immunology, The Affiliated Hospital of Inner Mongolia Medical University, Inner Mongolia 010050, P.R. China.; Inner Mongolia Key Laboratory for Pathogenesis and Diagnosis of Rheumatic and Autoimmune Diseases, Inner Mongolia 010110, P.R. China.
Publikováno v:
Journal of microbiology and biotechnology [J Microbiol Biotechnol] 2024 Jul 28; Vol. 34 (7), pp. 1376-1384. Date of Electronic Publication: 2024 Apr 29.
Autor:
Mortensen JS; Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark., Mikkelsen ANL; Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark., Wellendorph P; Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Publikováno v:
Expert opinion on therapeutic targets [Expert Opin Ther Targets] 2024 Jul; Vol. 28 (7), pp. 529-543. Date of Electronic Publication: 2024 Jul 27.
Autor:
Kukendrarajah K; Institute of Health Informatics, University College London, 222 Euston Road, NW1 2DA, United Kingdom; Barts Heart Centre, St Bartholomew's Hospital, West Smithfield, EC1A 7BE, United Kingdom. Electronic address: kishore.kukendrarajah.17@ucl.ac.uk., Farmaki AE; Institute of Health Informatics, University College London, 222 Euston Road, NW1 2DA, United Kingdom., Lambiase PD; Barts Heart Centre, St Bartholomew's Hospital, West Smithfield, EC1A 7BE, United Kingdom; Institute of Cardiovascular Science, University College London, Gower Street, WC1E 6HX, United Kingdom., Schilling R; Barts Heart Centre, St Bartholomew's Hospital, West Smithfield, EC1A 7BE, United Kingdom., Finan C; Institute of Cardiovascular Science, University College London, Gower Street, WC1E 6HX, United Kingdom; UCL British Heart Foundation Research Accelerator, United Kingdom; Division Heart and Lungs, Department of Cardiology, University Medical Center Utrecht, Utrecht University, the Netherlands., Floriaan Schmidt A; Institute of Cardiovascular Science, University College London, Gower Street, WC1E 6HX, United Kingdom; UCL British Heart Foundation Research Accelerator, United Kingdom; Division Heart and Lungs, Department of Cardiology, University Medical Center Utrecht, Utrecht University, the Netherlands; Department of Cardiology, Amsterdam Cardiovascular Sciences, Amsterdam University Medical Centres, University of Amsterdam, the Netherlands., Providencia R; Institute of Health Informatics, University College London, 222 Euston Road, NW1 2DA, United Kingdom; Barts Heart Centre, St Bartholomew's Hospital, West Smithfield, EC1A 7BE, United Kingdom.
Publikováno v:
EBioMedicine [EBioMedicine] 2024 Jul; Vol. 105, pp. 105194. Date of Electronic Publication: 2024 Jun 27.
Autor:
Yuan Y; Office of Clinical Pharmacology, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA., Li L; Office of Clinical Pharmacology, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA., Earp J; Office of Clinical Pharmacology, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA., Ma L; Office of Clinical Pharmacology, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA., Bhattaram VA; Office of Clinical Pharmacology, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA., Sharma V; Office of Clinical Pharmacology, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA., Tong A; Office of Clinical Pharmacology, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA., Wang Y; Office of Clinical Pharmacology, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA., Liu J; Office of Clinical Pharmacology, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA., Zhu H; Office of Clinical Pharmacology, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA.
Publikováno v:
Journal of clinical pharmacology [J Clin Pharmacol] 2024 Jul; Vol. 64 (7), pp. 799-809. Date of Electronic Publication: 2024 Mar 01.
Autor:
Maurer MS; Division of Cardiology, Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA., Soman P; University of Pittsburgh Medical Center, UPMC Heart and Vascular Institute, Cardiac Amyloidosis Center, Pittsburg, PA, USA., Hernandez A; Duke University School of Medicine, Duke Clinical Research Center, Durham, NC, USA., Garcia-Pavia P; Hospital Universitario Puerta de Hierro Majadahonda, IDIPHISA, CIBERCV, Madrid, Spain.; Spanish National Cardiovascular Research Institute (CNIC), Madrid, Spain., Signorovitch J; Analysis Group, Boston, MA, USA., Wei LJ; T.H. Chan School of Public Health, Biostatistics, Harvard University, Boston, MA, USA., Hanna M; Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH, USA., Ruberg FL; Chobanian and Avedisian School of Medicine, Department of Medicine, Boston University, Boston, MA, USA., Kittleson M; Cedars-Sinai, Smidt Heart Institute, Los Angeles, CA, USA., Kazi D; Beth Israel Deaconess Medical Center, Cardiac Critical Care Unit; Richard A. and Susan F. Smith Center for Outcomes Research in Cardiology, Health Economics, Boston, MA, USA., Dorbala S; Brigham and Women's Hospital, Cardiovascular Medicine, Nuclear Radiology, Boston, MA, USA., Hsu K; Amyloidosis Research Consortium, 320 Nevada Street, Suite 210, Newton, MA, 02460, USA., Lousada I; Amyloidosis Research Consortium, 320 Nevada Street, Suite 210, Newton, MA, 02460, USA. ILousada@arci.org., Adigun R; Center for Drug Evaluation and Research, Division of Cardiology and Nephrology, US Food and Drug Administration, Silver Spring, MD, USA., Dunnmon P; Janssen Research and Development Data Sciences, Cardiovascular/Metabolic and Pulmonary Hypertension, Raritan, NJ, USA., Kelly J; Department of Chemistry, Scripps Research Institute, San Diego, CA, USA., Gillmore J; UK National Amyloidosis Centre, London, UK.
Publikováno v:
Advances in therapy [Adv Ther] 2024 Jul; Vol. 41 (7), pp. 2723-2742. Date of Electronic Publication: 2024 Jun 04.